
|Articles|November 1, 2012
LNG-IUS may have potential in endometrial cancer
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
2
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
3
Individualized TRT demonstrates broad symptom improvements beyond sexual function
4
SMFM in midst of first annual High-Risk Pregnancy Awareness Week
5






